Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | APP | P05067 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 1/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2566987 | 0.84 | CYP3A4 (0.41) | CYP2D6CYP1A2CYP3A4APPRAB9A | |
| SCHEMBL22522160 | 0.84 | SLC2A1 (0.44) | SLC2A1 | |
| SCHEMBL20357815 | 0.81 | CYP3A4 (0.47) | CYP2D6CYP1A2CYP3A4CYP19A1CYP2C9 | |
| SCHEMBL5486265 | 0.81 | MAPT (0.44) | CYP2D6CYP1A2CYP3A4APPRAB9A | |
| SCHEMBL14431681 | 0.80 | CYP3A4 (0.44) | CYP2D6CYP1A2CYP3A4SMN1; SMN2CYP19A1 | |
| SCHEMBL4005060 | 0.80 | APP (0.46) | APPRAB9AMAPTNPC1SMN1; SMN2 | |
| SCHEMBL17694318 | 0.80 | CYP3A4 (0.33) | CYP2D6CYP1A2CYP3A4RAB9AMAPT | |
| SCHEMBL20357889 | 0.80 | RARB (0.46) | CYP2D6CYP1A2CYP3A4CYP19A1CYP2C9 | |
| SCHEMBL14539473 | 0.79 | APP (0.44) | CYP2D6CYP1A2CYP3A4APPRAB9A | |
| SCHEMBL11833351 | 0.78 | CYP3A4 (0.42) | CYP2D6CYP1A2CYP3A4RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1943239-B1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2011-11-09 | — | — | EP | claimed |
| US-7569415-B2 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. (US) | 2009-08-04 | — | — | US | claimed |
| US-7488834-B2 | Organic semiconductors | ALCATEL-LUCENT USA INC. (US) | 2009-02-10 | — | — | US | claimed |
| EP-1943239-A1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2008-07-16 | — | — | EP | claimed |
| EP-1943688-A1 | LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2008-07-16 | — | — | EP | claimed |
| EP-1943690-A1 | ORGANIC COMPOSITIONS | BASF SE (DE) | 2008-07-16 | — | — | EP | claimed |
| WO-2007039575-A1 | LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2007039547-A1 | ORGANIC COMPOSITIONS | BASF SE (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2007039574-A1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2007-04-12 | — | — | WO | claimed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | claimed |
| US-20070077681-A1 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | claimed |
| US-20070075630-A1 | Organic compositions | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | claimed |
| EP-1943239-B1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-7569415-B2 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. (US) | 2009-08-04 | — | — | US | disclosed |
| US-7569415-B2 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. (US) | 2009-08-04 | — | — | US | disclosed |
| US-7488834-B2 | Organic semiconductors | ALCATEL-LUCENT USA INC. (US) | 2009-02-10 | — | — | US | disclosed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070077681-A1 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070077681-A1 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078267-A1 | Organic semiconductors | ORC3, C1S, C5 | CYP2D6 3097/4885CYP1A2 1375/4885CYP3A4 1717/4885 |
| US-20070075630-A1 | Organic compositions | BPNT1, RFT1, FERMT2 | CYP2D6 1780/4885CYP1A2 990/4885CYP3A4 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.